Clinical trial
Mucomyst for Hepatitis C
NCT00493610 · US Department of Veterans Affairs, U.S. Fed · Suspended
Key facts
| NCT number | NCT00493610 |
|---|---|
| Title | Mucomyst for Hepatitis C |
| Official title | Use of Mucomyst (NAC) to Ameliorate Oxidant Stress as Measured by Surrogate Serum in Patients With Hepatitis C |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | West Virginia University |
| Status | Suspended |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | N-acetylcysteine(Mucomyst) |
| Enrollment | 5 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jun 28, 2007 |
| Last update posted | Jan 8, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: